Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Barnadas, Céline ^a   Tichit, Magali ^c   Bouchier, Christiane ^c   Ratsimbasoa, Arsène ^b   Randrianasolo, Laurence ^b   Raherinjafy, Rogelin ^b   Jahevitra, Martial ^b   Picot, Stéphane ^a   Ménard, Didier ^b  

^a UNIVERSITÉ LYON 1   (France)

^b INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTESUNATE; FANSIDAR; TETRACYCLINE; ANTIMALARIAL AGENT; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; PROTOZOAL PROTEIN; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE; UNCLASSIFIED DRUG;

ADJUSTMENT; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CODON; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DHFR GENE; DHPS GENE; FEMALE; FOLLOW UP; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFANT; MADAGASCAR; MALARIA; MALE; MONITORING; MONOTHERAPY; MUTANT; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; PARASITOLOGY; PLASMODIUM VIVAX; POLICY; PREVALENCE; PROTOZOAL INFECTION; SAMPLE; THERAPY EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; WILD TYPE; ANIMAL; DNA SEQUENCE; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; MUTATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; HUMANS; INFANT; MADAGASCAR; MALARIA, VIVAX; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; PYRIMETHAMINE; SEQUENCE ANALYSIS, DNA; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE; TREATMENT OUTCOME;

EID: 40949085279     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-35     Document Type: Article

References (40)

1. The neglected burden of Plasmodium vivax malaria. K Mendis BJ Sina P Marchesini R Carter, Am J Trop Med Hyg 2001 64 1-2 Suppl 97 106 11425182
2. Which malaria rapid test for Madagascar? Field and laboratory evaluation of three tests and expert microscopy of samples from suspected malaria patients in Madagascar. A Ratsimbasoa A Randriamanantena R Raherinjafy N Rasoarilalao D Menard, Am J Trop Med Hyg 2007 76 3 481 485 17360871
3. Moderate transmission but high prevalence of malaria in Madagascar. V Robert G Le Goff L Andrianaivolambo FM Randimby O Domarle M Randrianarivelojosia V Raharimanga A Raveloson C Ravaonjanahary F Ariey, Int J Parasitol 2006 36 12 1273 1281 10.1016/j.ijpara.2006.06.005 16842796
4. Enquête auprès des Ménages. Institut National de la Statistique de Madagascar 2002 71 83
5. Mortalité des enfants de moins de 5 ans à Madagascar. SA Jeremiah M, Enquête Démographique et de la Santé III à Madagascar 2004 191 201
6. Multiple Indicator Cluster Survey (MICS). UNICEF,, http://www.childinfo. org/MICS2/newreports/madagascar/madagascar.pdf, 2000
7. Paludisme sur les hautes terres centrales de Madagascar: stratégies de lutte. RT Rabarijaona LP Ranaivo LH, Raharimalala LA, Rakotomanana F, Rakotondraibe EM, Ramarosandratana B, Rakotoson JD, Rakotonjanabelo LA, Tafangy PB, Méd Trop 2006 66 5 504 512
8. Monitoring susceptibility to sulfadoxine-pyrimethamine among cases of uncomplicated, Plasmodium falciparum malaria in Saharevo, Madagascar. L Randrianasolo A Randriamanantena L Ranarivelo A Ratsimbasoa O Domarle M Randrianarivelojosia, Ann Trop Med Parasitol 2004 98 6 551 554 10.1179/000349804225021398 15324461
9. Current absence of pyrimethamine resistance of Plasmodium falciparum in Madagascar. M Randrianarivelojosia F Ariey LA Raharimalala D Parzy C Rogier R Jambou, Trans R Soc Trop Med Hyg 2002 96 5 557 559 10.1016/S0035-9203(02)90441-4 12474489
10. In vitro sensitivity of Plasmodium falciparum to amodiaquine compared with other major antimalarials in Madagascar. M Randrianarivelojosia JL Harisoa LP Rabarijaona LA Raharimalala L Ranaivo V Pietra JB Duchemin F Rakotomanana V Robert P Mauclere F Ariey, Parassitologia 2002 44 3-4 141 147 12701375
11. Monitoring the drug-sensitivity of Plasmodium falciparum in coastal towns in Madagascar by use of in vitro chemosensitivity and mutation detection tests. MA Rason F Ariey L Rafidimanantsoa BH Andrianantenaina JL Sahondra Harisoa M Randrianarivelojosia, Parasite 2002 9 3 247 253 12375368
12. Antifolates can have a role in the treatment of Plasmodium vivax. VN Hawkins H Joshi K Rungsihirunrat K Na-Bangchang CH Sibley, Trends Parasitol 2007 23 5 213 222 10.1016/j.pt.2007.03.002 17368986
13. Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance. PE de Pecoulas R Tahar T Ouatas A Mazabraud LK Basco, Mol Biochem Parasitol 1998 92 2 265 273 10.1016/S0166-6851(97)00247-8 9657331
14. Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates. M Imwong S Pukrittakayamee S Looareesuwan G Pasvol J Poirreiz NJ White G Snounou, Antimicrob Agents Chemother 2001 45 11 3122 3127 11600366 10.1128/AAC.45.11. 3122-3127.2001
15. Cultivation of Plasmodium vivax. R Udomsangpetch O Kaneko K Chotivanich J Sattabongkot, Trends Parasitol 2008 24 2 85 88 10.1016/j.pt.2007.09.010 18180202
16. Monitoring antimalarial drug resistance, Report of a WHO consultation. WHO, Geneva, Switzerland, World Health Organization 2002
17. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. M Imwong S Pukrittayakamee AC Gruner L Renia F Letourneur S Looareesuwan NJ White G Snounou, Malar J 2005 4 1 20 15854233 10.1186/1475-2875-4-20
18. Polymorphism at the merozoite surface protein-3alpha locus of Plasmodium vivax: global and local diversity. MC Bruce MR Galinski JW Barnwell G Snounou KP Day, Am J Trop Med Hyg 1999 61 4 518 525 10548283
19. Meager genetic variability of the human malaria agent Plasmodium vivax. MC Leclerc P Durand C Gauthier S Patot N Billotte M Menegon C Severini FJ Ayala F Renaud, Proc Natl Acad Sci U S A 2004 101 40 14455 14460 15328406 10.1073/pnas.0405186101
20. Microsatellite variation, repeat array length, and population history of Plasmodium vivax. M Imwong D Sudimack S Pukrittayakamee L Osorio JM Carlton NP Day NJ White TJ Anderson, Mol Biol Evol 2006 23 5 1016 1018 10.1093/molbev/ msj116 16507919
21. Simultaneous identification of the four human Plasmodium species and quantification of Plasmodium DNA load in human blood by real-time polymerase chain reaction. F de Monbrison C Angei A Staal K Kaiser S Picot, Trans R Soc Trop Med Hyg 2003 97 4 387 390 10.1016/S0035-9203(03)90065-4 15259463
22. Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure. M Imwong S Pukrittayakamee L Renia F Letourneur JP Charlieu U Leartsakulpanich S Looareesuwan NJ White G Snounou, Antimicrob Agents Chemother 2003 47 5 1514 1521 12709316 10.1128/AAC.47.5.1514-1521.2003
23. Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site. M Korsinczky K Fischer N Chen J Baker K Rieckmann Q Cheng, Antimicrob Agents Chemother 2004 48 6 2214 2222 15155224 10.1128/AAC.48.6.2214-2222.2004
24. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. TA Hall, Nucl Acids Symp Ser 1999 95 98
25. Analysis of the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene sequence. P Eldin de Pecoulas LK Basco R Tahar T Ouatas A Mazabraud, Gene 1998 211 1 177 185 10.1016/S0378-1119(98)00118-8 9573357
26. The dual origin of the Malagasy in Island Southeast Asia and East Africa: evidence from maternal and paternal lineages. ME Hurles BC Sykes MA Jobling P Forster, Am J Hum Genet 2005 76 5 894 901 15793703 10.1086/430051
27. Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system. MD Hastings JD Maguire MJ Bangs PA Zimmerman JC Reeder JK Baird CH Sibley, Antimicrob Agents Chemother 2005 49 2 733 740 15673758 10.1128/AAC.49.2.733-740.2005
28. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. AM Nzila EK Mberu J Sulo H Dayo PA Winstanley CH Sibley WM Watkins, Antimicrob Agents Chemother 2000 44 4 991 996 10722502 10.1128/AAC.44.4.991-996.2000
29. Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum. AM Nzila E Nduati EK Mberu C Hopkins Sibley SA Monks PA Winstanley WM Watkins, J Infect Dis 2000 181 6 2023 2028 10.1086/315520 10837185
30. Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine. MD Hastings KM Porter JD Maguire I Susanti W Kania MJ Bangs CH Sibley JK Baird, J Infect Dis 2004 189 4 744 750 10.1086/381397 14767830
31. Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax. MD Hastings CH Sibley, Proc Natl Acad Sci U S A 2002 99 20 13137 13141 12198181 10.1073/pnas.182295999
32. Plasmodium vivax dihydrofolate reductase point mutations from the Indian subcontinent. S Kaur SK Prajapati K Kalyanaraman A Mohmmed H Joshi VS Chauhan, Acta Trop 2006 97 2 174 180 10.1016/j.actatropica.2005.10.003 16310156
33. Antifolate screening using yeast expressing Plasmodium vivax dihydrofolate reductase and in vitro drug susceptibility assay for Plasmodium falciparum. LY Djapa LK Basco R Zelikson A Rosowsky JA Djaman JN Yonkeu M Bolotin-Fukuhara A Mazabraud, Mol Biochem Parasitol 2007 156 1 89 92 10.1016/j.molbiopara.2007.07.009 17727978
34. Chimiorésistance de Plasmodium falciparum sur les régions cotières malgaches. RL Randrianarivelojosia M Randriamanantena A, Jambou R, Méd Trop 2000 60 243 249
35. DHFR and Plasmodium falciparum resistance to antifolates: search for other mutations in the Indian Ocean region. RL Randrianarivelojosia M Parzi D, Roux JF, Jambou R, Bull Soc Path Exot 1999 92 282
36. WHO Expert Comittee on Malaria. WHO, Geneva, Switzerland, World Health Organization 2000
37. Effects of Plasmodium vivax malaria in pregnancy. F Nosten R McGready JA Simpson KL Thwai S Balkan T Cho L Hkirijaroen S Looareesuwan NJ White, Lancet 1999 354 9178 546 549 10.1016/S0140-6736(98)09247-2 10470698
38. Epidemiology of malaria in pregnancy in central India. N Singh MM Shukla VP Sharma, Bull World Health Organ 1999 77 7 567 572 10444880
39. Primer3 on the WWW for general users and for biologist programmers. S Rozen H Skaletsky, Methods Mol Biol 2000 132 365 386 10547847
40. Extensive polymorphism in the Plasmodium vivax merozoite surface coat protein MSP-3alpha is limited to specific domains. JC Rayner V Corredor D Feldman P Ingravallo F Iderabdullah MR Galinski JW Barnwell, Parasitology 2002 125 Pt 5 393 405 10.1017/S0031182002002317 12458823